Intellijoint Surgical, Inc. Workstation, G2, Configured (P/N 000-0241) Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Workstation, G2, Configured (P/N 000-0241)
Brand
Intellijoint Surgical, Inc.
Lot Codes / Batch Numbers
Apple MacBook Serial Numbers: C02R4A0ZG8WN, C02R4CTLG8WN, C02R4CVYG8WN, C02R4CTHG8WN, C02R4CUZG8WN, C02R4CV6G8WN, C02R4CWZG8WN Additional units discovered 09/18/2019: C02R4CQ5G8WN, C02R4CULG8WN, C02R4CVWG8WN, C02R4CWYG8WN, C02R4CQ6G8WN, C02R4CUPG8WN, C02R4CSSG8WN, C02R4CTQG8WN, C02R4CSZG8WN, C02R4CUSG8WN, C02R4CUXG8WN, C02R4CUQG8WN, C02R4CU0G8WN, C02R4A6PG8WN, C02R4CTMG8WN, 02R4CUNG8WN
Products Sold
Apple MacBook Serial Numbers: C02R4A0ZG8WN, C02R4CTLG8WN, C02R4CVYG8WN, C02R4CTHG8WN, C02R4CUZG8WN, C02R4CV6G8WN, C02R4CWZG8WN Additional units discovered 09/18/2019: C02R4CQ5G8WN, C02R4CULG8WN, C02R4CVWG8WN, C02R4CWYG8WN, C02R4CQ6G8WN, C02R4CUPG8WN, C02R4CSSG8WN, C02R4CTQG8WN, C02R4CSZG8WN, C02R4CUSG8WN, C02R4CUXG8WN, C02R4CUQG8WN, C02R4CU0G8WN, C02R4A6PG8WN, C02R4CTMG8WN, 02R4CUNG8WN
Intellijoint Surgical, Inc. is recalling Workstation, G2, Configured (P/N 000-0241) due to Apple has determined that, in a limited number of older generation 15-inch MacBook Pro Units, the battery may overheat and pose a fire safety risk. T. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Apple has determined that, in a limited number of older generation 15-inch MacBook Pro Units, the battery may overheat and pose a fire safety risk. To date, Intellijoint has distributed, 15-inch MacBook Pros which are the Workstation component (affected P/N 000-0241) in the Intellijoint HIP System.
Recommended Action
Per FDA guidance
The firm initiated the recall by email on 06/28/2019. The letter requested the distributor locate and return the MacBooks.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CA, IL, NY, RI, TX
Page updated: Jan 10, 2026